Skip to main content
. 2020 Jun 5;10(2):e46. doi: 10.1002/ctm2.46

FIGURE 2.

FIGURE 2

Inhibitory effects of acRoots in proliferation of cancer cells 24, 48, and 72 h after treatment with acRoots at doses of 1, 3, 5, 6, 10, 30, 50, and 100 mg/mL. Cancer cells mainly include leukemia cells (Raji [A] and Meg [B]), prostatic cancer cells (Du145 [C]), pancreatic cancer cells (Panc‐1 [D], SW1990 [E], Mia‐paca [F], and CFPAC [H]), pancreatic stellate cells (PSC [G]), glioma cells (U251 [I]), umbilical vein endothelial cells (HUVEC [J]), colon cancer cells (HT‐29 [K], RKO [L], Caco‐2 [O], and SW480 [R]), gastric cancer cells (AGS [M], MGC803 [N], and SGC‐7901 [Q]), breast cancer cells (MCF‐7 [S] and MDA‐MB‐231 [T]), esophagus cancer cells (TE‐1 [U] and Eca109 [P]), and endometrial adenocarcinoma cell (RL95‐2 [V]).